Taconic Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Taconic Capital Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-100,000	Closed	-$4.6M	–	41
2016 Q3	$4.6M	Sell	100,000 -120,000	-55%	-$6.26M	0.57%	21
2016 Q2	$11.1M	Sell	220,000 -250,000	-53%	-$13.3M	0.83%	25
2016 Q1	$25.1M	Buy	470,000 +10,000	+2%	+$587K	0.72%	24
2015 Q4	$30.2M	Sell	460,000 -125,000	-21%	-$7.72M	0.99%	21
2015 Q3	$33M	Buy	+585,000	New	+$37.9M	1.22%	18

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Taconic Capital Advisors's TEVA Position: Q4 2016 in Review

Taconic Capital Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 100,000 shares — an estimated $4.6M sold.

Taconic Capital Advisors first reported a position in TEVA in Q3 2015 and held it in 5 quarters. The position peaked at $33M in Q3 2015. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Taconic Capital Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Taconic Capital Advisors sold 100,000 Teva Pharmaceuticals shares in Q4 2016, an estimated $4.6M.
Taconic Capital Advisors first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Taconic Capital Advisors's Teva Pharmaceuticals position peaked at $33M in Q3 2015.
739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Taconic Capital Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.